Fetomaternal Medicine
Tuesday, March 22, 2016
08:30-10:00 | CESAREAN SECTION |
Chairpersons | Aris Antsaklis, Greece Julia Unterscheider, Australia |
08:30-09:30 | Debate: There is no place for VBAC: Once a Caesarean, always a Caesarean Not True: Aris Antsaklis, Greece True: Ben W.J. Mol, Australia Discussion |
09:30-10:00 | All pregnant women should be offered the possibility of a Caesarean section Julia Unterscheider, Australia |
10:00-10:30 | Coffee Break |
10:20-11:50 | TOCOLYSIS |
Chairpersons | Shaun Brennecke, Australia Ben W.J. Mol, Australia |
10:20-11:20 | Debate: There is no place for tocolysis in threatened preterm labour Pro: Ryan Hodges, Australia Con: Jon Hyett, Australia Discussion |
11:20-11:50 | Routine cervical length by TV scan at mid-gestation for preterm delivery screening Penny Sheehan, Australia |
11:50-12:10 | Break |
12:10-13:40 | CELL-FREE DNA (cfDNA) TESTING Supported by Roche |
Capsule | Cell-free DNA (cfDNA) testing is revolutionizing prenatal care by providing a simple, highly accurate, non-invasive screening method for aneuploidy. As demand for cfDNA testing is rising quickly, an increasing number of physicians are offering Non-invasive prenatal testing (NIPT) in their practice. However questions around clinical implementation, patient counseling and future applications remain. What do you and your patients need to know about cfDNA testing? How do we best integrate cfDNA testing into our clinical practice? Is expanding the indications for cfDNA testing useful? Where do we go from here? |
Chairpersons | Ricardo Palma-Dias, Australia Maximilian Schmid, Austria |
Screening in pregnancy: Traditional screening for aneuploidy and prediction of preeclampsia Jon Hyett, Australia |
|
CfDNA testing technology and biology: What do you really need to know? Graeme Suthers, Australia |
|
Implementation of cfDNA testing in clinical practice: Principles and guidelines Fabricio Costa, Australia |
|
Non-invasive prenatal testing: Future perspectives Maximilian Schmid, Austria |
13:40-14:30 | Lunch Break |
14:30-16:00 | PROGESTERONE SUPPORT DURING PREGNANCY |
Capsule | Progesterone use to arrest premature labour is being used with increasing frequency |
Chairpersons | Ryan Hodges, Australia John Regan, Australia |
14:30-14:45 | Debate: Progesterone should be the cornerstone of prevention of preterm birth Pro: Penny Sheehan, Australia Con: Euan Wallace, Australia Discussion |
15:15-15:40 | Is progesterone effective in PTL and multiple pregnanices? Ben W.J. Mol, Australia |
15:40-16:00 | Progesterone for early pregnancy loss Salim Daya, Canada |
16:00-16:30 | Coffee break |
16:30-18:00 | US: PRENATAL DIAGNOSIS |
Chairpersons | Fabricio Costa, Australia Jon Hyett, Australia |
16:30-16:50 | Is routine 3rd trimester scanning and cerebro-placental ratio (CPR) justifiable in clinical practice? Fergus Scott, Australia |
16:50-17:15 | Fetal echogenic lung lesions: Controversies in nomenclature, follow-up and treatment Fabricio Costa, Australia |
17:15-17:35 | Is laser recommended for stage I twin-to-twin transfusion syndrome (TTTS)? Mark Teoh, Australia |
17:35-18:00 | Amniocentesis to define a fetal inflammatory response in premature rupture of membranes (PPRoM) / spontaneous preterm labour (sPTL) Jon Hyett , Australia |
Wednesday, March 23, 2016
08:30-10:00 | OPERATIVE OBSTETRICS |
Chairperson | Aris Antsaklis, Greece John Campbell, Australia |
08:30-09:15 | Debate: Should we keep using Forceps and Vacuum? Yes: John Regan, Australia No: Aris Antsaklis, Greece Discussion |
09:15-09:35 | Myomectomy during CS Zion Ben Rafael, Israel |
09:35-10:00 | Surgical management of placental adhesion Elske Posma, Australia |
10:00-10:20 | Coffee Break |
10:20-11:50 | PREMATURE LABOUR |
Capsule | Prevention of premature labour remains one of the major challenges in obstetrics |
Chairpersons | Ben W.J. Mol, Australia Ryan Hodges, Australia |
10:20-11:20 | Debate: Proposition: Testing for fetal fibronectin should be done in all women with threatened preterm labour Shaun Brennecke, Australia Opposition: Ben W.J. Mol, Australia Discussion |
11:20-11:50 | The pros and cons of corticosteroids should be used prior to elective CS near term Julia Unterscheider, Australia |
11:50-12:10 | Break |
12:10-13:40 | PREECLAMPSIA |
Capsule | The ability to predict changes in Markers, weeks before the onset of preeclampsia is the first step in offering prevention plan. What is the medical benefit of prediction? |
Chairpersons | Penny Sheehan, Australia Shaun P. Brennecke, Australia |
12:10-12:30 | Could close surveillance of the patient at risk of preeclampsia prevent the pathology or save maternal and fetal life? Shaun P. Brennecke, Australia |
12:30-12:55 | The best method to predict Hypertension Euan Wallace, Australia |
12:55-13:40 | Debate: Is LMWH useful in the prevention of preeclampsia? Yes: Gustaaf Dekker, Australia No: Joanne Said, Australia Discussion |
13:40-14:30 | Lunch break |
14:30-16:00 | OBESITY IN PREGNANCY |
Capsule | Obesity was declared an epidemic, obstetric complications are now being recognized. What are the implications? |
Chairpersons | Michael Permezel, Australia Alexis Shub, Australia |
14:30-15:00 | What should be the target birth weight? Michael Permezel, Australia |
15:00-15:30 | The new ADIPS criteria for GDM should be applied universally Alexis Shub, Australia |
15:30-16:00 | Improving perinatal health care for Aboriginal women as a crucial strategy to address inter-generational diabetes Jacqueline Boyle, Australia |
16:00-16:30 | Coffee Break |
16:30-18:00 | FETAL MONITORING |
Capsule | Fetal monitoring remains controversial despite years of use and computerized improvements. Where do we come from? Where are we going? Can we do without it or should we keep improving the technique? |
Chairpersons | Micahel Premezel, Australia Aris Antsaklis, Greece |
16:30-17:00 | The new FIGO guidelines on FHR monitoring Henry G. Murray, Australia |
17:00-17:30 | Auscultation vs. FHR Aris Antsaklis, Greece |
17:30-18:00 | Improving pregnancy care for Aboriginal and Torres Strait Islander women: a national continuous quality improvement project Jacqueline Boyle, Australia |